Ignite Creation Date:
2025-12-24 @ 2:38 PM
Ignite Modification Date:
2026-01-13 @ 3:48 AM
Study NCT ID:
NCT06938659
Status:
NOT_YET_RECRUITING
Last Update Posted:
2025-04-22
First Post:
2025-03-12
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Low Dose Emicizumab vs Low Dose Factor VIII in Prophylaxis in Hemophilia A Patients
Sponsor:
Dhaka Medical College
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
ERC-DMC/ECC/2024/215
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None